- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00006146
Half-Dose Flu Vaccine Study in Healthy Adults
Evaluation of the Immunogenicity of Low Dose Trivalent Inactivated Influenza Vaccine in Healthy Adults
It appears likely that there will be a delay and possibly a reduction in the amount of influenza vaccine available for the 2000-2001 influenza season. One possible way of increasing the availability of influenza vaccine for this year is to use a half-dose in healthy adults. The objective of this study is to determine if the immune system responds to a half-dose the same way it responds to a whole dose. This study will use the currently approved inactivated influenza vaccine in healthy adults ages 18 to 49 years old.
If the immune response to the half-dose is not significantly different than the immune response generated to the whole dose, this could be a strategy to extend the amount of vaccine that could be available in this age group.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Studietype
Registrering
Fase
- Fase 2
Kontakter og plasseringer
Studiesteder
-
-
California
-
Torrance, California, Forente stater, 90502
- UCLA Center for Vaccine Research
-
-
Maryland
-
College Park, Maryland, Forente stater
- Maryland CARES
-
-
Missouri
-
St Louis, Missouri, Forente stater, 63110
- Center for Vaccine Development
-
-
New York
-
Rochester, New York, Forente stater, 14642
- Univ of Rochester Medical Center
-
-
Ohio
-
Cincinnati, Ohio, Forente stater, 45206
- Inf Dis Clinic at Gamble Research Clinic and Bethesda Hosp
-
-
Texas
-
Houston, Texas, Forente stater, 77030
- Baylor College of Medicine
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
Volunteers may be eligible for this trial if they:
- Are able to and have given informed consent.
- Are able to understand and comply with all study procedures and to complete study diary.
- Are aged 18 to 49 years.
- Are female, and are not pregnant.
- Are available for all study visits.
Exclusion Criteria:
Volunteers will not be eligible for this trial if they:
- Are allergic to eggs or egg products.
- Have a current chronic medical condition for which influenza vaccine is normally recommended.
- Have received experimental vaccines or medications within 30 days of study entry.
- Have received parenteral immunoglobulin within 30 days of study entry.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: John Treanor, Univ of Rochester Medical Center
Studierekorddatoer
Studer hoveddatoer
Studiestart
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- DMID 00-009
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .